Basic Information
ARCALIS is a joint venture between Axcelead and Arcturus, with Arcturus holding a 49% stake. The facility, located in Minamisoma, Japan, aims to provide cGMP integrated vaccine production from messenger RNA active pharmaceutical ingredients to bulk nanoparticle formulations.
ARCALIS, Inc.
Fukushima,Japan
less than 15 people
February 18, 2021
--